Teachers, state employees and state-supported local employees would receive raises of 3% in each year of the new two-year budget under an agreement that General Assembly budget negotiators ...

There was little difference between icotrokinra and placebo on safety, with 49.3% of those on the IL-23 inhibitor and 49.1% of the placebo group reporting a treatment-emergent adverse event (TEAE ...

with overexpression of B7-H3 seen in around two-thirds of cases. It is an aggressive tumour, metastasising rapidly, and has a five-year survival rate of only 3%.